CYTOTUNE
Live / Registered — Cancelled — Section 71 (as of 16 Jan 2026)
What this means for you
Registered since 02 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79242493
- Registration number
- 5790755
- Mark type
- Stylized text
- Filed
- 08 Aug 2018
- Published for opposition
- 16 Apr 2019
- Registered
- 02 Jul 2019
- Attorney of record
- Stacey R. Halpern
Goods and services
- Class 001 — Chemicals: Protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicals, namely, polypeptides for in vitro and in vivo scientific and research use; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research, reagents, cosmetics, and pharmaceuticals
- Class 005 — Pharmaceuticals: Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, AIDS, influenza, and Alzheimer's disease; preparations for gene therapy, namely, introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and growth media for medical use, namely, for gene therapy
- Class 042 — Scientific and technological services: Testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, namely, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science
Owner
- ID Pharma Co., Ltd., Ibaraki, JP
- ID Pharma Co., Ltd., Ibaraki, JP
- ID Pharma Co., Ltd., Ibaraki, JP
Prosecution history
- 16 Sept 2026 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 16 Jan 2026 — CANCELLED SECTION 71
- 02 Jul 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 14 Sept 2020 — INTERNATIONAL REGISTRATION RENEWED
- 06 Dec 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Oct 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Oct 2019 — FINAL DISPOSITION PROCESSED
- 02 Oct 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 10 May 2019 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 16 Apr 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Apr 2019 — PUBLISHED FOR OPPOSITION
- 27 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Feb 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED